Orthofix International (OFIX) Misses Q1 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Orthofix Reports First Quarter 2022 Results
May 6, 2022 7:00 AM EDTNet sales of $106.4 million, an increase of 1% on a reported basis and 2% on a constant currency basis over prior year New product sales drive solid growth in Biologics, Spinal Implants, and Orthopedics FDA grants PMA for AccelStim bone growth stimulator LIPUS technology expands our indications into fresh fracture care FDA clearance received for the TrueLok EVO Ring Fixation system, which enables clear radiographic visualization Reaffirming 2022 guidance
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today reported... More
